Topic

Nourianz (istradefylline)

A collection of 34 issues

Lowering Out-of-Pocket Costs for Nourianz (Istradefylline) with Blue Cross Blue Shield in Washington: Copay Programs, Tiering Strategies & Appeals

Answer Box: Getting Nourianz Covered at the Lowest Cost Nourianz (istradefylline) is covered by Premera Blue Cross and Regence BlueShield in Washington as a specialty-tier drug, typically requiring prior authorization. Most commercially insured patients can reduce costs to $20-60/month using the Kyowa Kirin Cares copay program (up to $5,
6 min read

Work With Your Doctor to Get Nourianz (Istradefylline) Approved by UnitedHealthcare in New York: Complete Provider Collaboration Guide

Answer Box: Getting Nourianz Approved by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Nourianz (istradefylline) with step therapy requirements. To get approval in New York: 1. Document failed trials of amantadine, MAO-B inhibitors (rasagiline/selegiline), and COMT inhibitors (entacapone) 2. Submit through OptumRx via provider portal or call
7 min read

How to Renew Nourianz (Istradefylline) Coverage with Blue Cross Blue Shield in Ohio: Annual Requirements and Timeline

Answer Box: Blue Cross Blue Shield plans in Ohio typically require annual prior authorization renewal for Nourianz (istradefylline), with reapproval depending on documented continued benefit and ongoing use with carbidopa/levodopa. Start the renewal process 30-60 days before expiration by scheduling a follow-up visit to document objective response (reduced "
5 min read

How to Get Nourianz (istradefylline) Covered by Aetna CVS Health in California: Prior Authorization Forms, Timelines, and State Appeal Rights

Answer Box: Getting Nourianz Covered by Aetna CVS Health in California Nourianz (istradefylline) requires prior authorization from Aetna CVS Health for Parkinson's disease OFF episodes. To get approved in California: (1) Submit PA form via Availity portal with documented OFF episodes ≥2 hours/day, concurrent levodopa/carbidopa use,
5 min read